Background: Organ dysfunction consequent to infection ('severe sepsis') is the leading cause of admission to an intensive care unit (ICU). In both animal models and early clinical studies the calcium channel sensitizer levosimendan has been demonstrated t
The heart is one of the organs most vulnerable to sepsis. This review describes the general characte...
Levosimendan is an inodilator that promotes cardiac contractility primarily through calcium sensitiz...
Background: Levosimendan has been proposed as an attractive alternative to adrenergic agents for the...
Background: In septic shock, cardiovascular resuscitation using catecholamine vasopressors and inotr...
Sepsis-related cardiovascular dysfunction associated with fluid-unresponsive tissue hypoperfusion mi...
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may i...
PURPOSE Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. ...
Levosimendan is a calcium sensitizer and its inotropic effect is mainly attributed to the troponin C...
BACKGROUND: Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may ...
It has been proposed that vasodilatory therapy may increase microcirculatory blood flow and improve ...
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for treatment of ...
Renal dysfunction is common in clinical settings in which cardiac function is compromised such as he...
Renal dysfunction is common in clinical settings in which cardiac function is compromised such as he...
The calcium sensitiser levosimendan, which is used as an inodilator to treat decompensated heart fai...
Purpose Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. The...
The heart is one of the organs most vulnerable to sepsis. This review describes the general characte...
Levosimendan is an inodilator that promotes cardiac contractility primarily through calcium sensitiz...
Background: Levosimendan has been proposed as an attractive alternative to adrenergic agents for the...
Background: In septic shock, cardiovascular resuscitation using catecholamine vasopressors and inotr...
Sepsis-related cardiovascular dysfunction associated with fluid-unresponsive tissue hypoperfusion mi...
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may i...
PURPOSE Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. ...
Levosimendan is a calcium sensitizer and its inotropic effect is mainly attributed to the troponin C...
BACKGROUND: Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may ...
It has been proposed that vasodilatory therapy may increase microcirculatory blood flow and improve ...
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for treatment of ...
Renal dysfunction is common in clinical settings in which cardiac function is compromised such as he...
Renal dysfunction is common in clinical settings in which cardiac function is compromised such as he...
The calcium sensitiser levosimendan, which is used as an inodilator to treat decompensated heart fai...
Purpose Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. The...
The heart is one of the organs most vulnerable to sepsis. This review describes the general characte...
Levosimendan is an inodilator that promotes cardiac contractility primarily through calcium sensitiz...
Background: Levosimendan has been proposed as an attractive alternative to adrenergic agents for the...